Neurimmune's Milestone Payment Round

Neurimmune raised a round of funding on September 18, 2018. Investors include Ono Pharmaceuticals.

Neurimmune focuses on the development of immunotherapeutics for the treatment and prevention of human disorders with high unmet medical needs.…

Articles about Neurimmune's Milestone Payment Round: